Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Robert Haigis"'
Autor:
Amy Mueller, Karen Gutekunst, Tamsen Dunn, Leonard Buchner, Anita Iyer, Margaret Porter, Kristen Meier, Nitin Udar, Paul Wenz, Diane Ward, Jing Lu, Aaron Wise, Shannon E. Smith, Robert Haigis, Shivani Dhillon
Publikováno v:
The Journal of Molecular Diagnostics. 22:159-178
A next-generation sequencing method was developed that can distinguish single-stranded modifications from low-frequency somatic mutations present on both strands of DNA in formalin-fixed paraffin-embedded colorectal cancer samples. We applied this me
Autor:
Shile Zhang, Kristina M. Kruglyak, Mahdi Golkaram, Robert Haigis, Raakhee Vijayaraghavan, Sven Bilke, Traci Pawlowski, Shannon Kaplan, Joyee Yao, Li Liu, Michael L. Salmans
Publikováno v:
Cancer Research. 80:1993-1993
Recent advances in cancer immunotherapy have revolutionized cancer treatment. Notably, pembrolizumab - an anti-PD1 checkpoint inhibitor - has been approved as first-line treatment for metastatic non-small cell lung cancer. Clinical response to checkp
Autor:
Traci Pawlowski, Charlene Echegaray, K. O’Brien, Brian Crain, D. Lee, Robert Haigis, J. Dockter, Jennifer Silhavy, Tingting Du, Raakhee Vijayaraghavan, R. Garcia, N. Haseley, I. Deras, A. Mentzer, J. Lee, A. Yazdanparast, Tingting Jiang, Chen Zhao, A. Purdy
Publikováno v:
Annals of Oncology. 30:v575-v576
Background We developed a tumor-only NGS assay (TruSight assay), a 523 gene panel covering 1.94 megabases (Mb), that detects small DNA variants, provides a microsatellite instability (MSI) score, and estimates tumor mutational burden (TMB) from FFPE
Autor:
Margaret Porter, Tamsen Dunn, Shannon E. Smith, Nitin Udar, Desiree Lee, Anita Iyer, Robert Haigis
Publikováno v:
Cancer Research. 76:3638-3638
Introduction: Next generation sequencing (NGS) is a highly sensitive method for detecting somatic mutations. Mutations in NRAS and KRAS may affect up to 50% of patients with colorectal cancer (CRC). Recent data suggest the clinical benefit of panitum
Autor:
Elizabeth L. Mather, Meredith Van Dyke, Huong Tang, Marjan Haghnia, Sagarika Tiwari, Madhushree Ghosh, Lihua Wang, William G. Weisburg, Robert Haigis, Andrea J. Kraft, Jiang Fan, Michael E. Bose, Tingquo Luo, Kelly J. Henrickson, Swati Kumar
Community-acquired pneumonia (CAP) and sepsis are important causes of morbidity and mortality. We describe the development of two molecular assays for the detection of 11 common viral and bacterial agents of CAP and sepsis: influenza virus A, influen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9aa66226953a408135183e311cc04b58
https://europepmc.org/articles/PMC2546717/
https://europepmc.org/articles/PMC2546717/
Autor:
Qingxiu Zhang, Erich Jaeger, Robert Haigis, Maryam Zenali, Nitin Udar, Thomas Gros, Mark T. Ross, Agda Karina Lucio-Eterovic
Publikováno v:
Journal of Clinical Oncology. 31:e22177-e22177
e22177 Background: Low frequency variant detection by sequencing is a highly desired goal for therapy selection in cancer especially the detection of actionable targets. The lower limit of detection using Sanger sequening is ~20% minor allele frequen